Industries > Pharma > Chinese Pharmaceutical Market Forecast 2017-2027

Chinese Pharmaceutical Market Forecast 2017-2027

Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics

PUBLISHED: 18 September 2017
PAGES: 253
PRODUCT CODE: PHA0238

Clear
WOOCS 2.2.1

The Chinese Pharmaceutical market is expected to grow at a CAGR of 12.3% in the second half of the forecast period. The Chinese Pharmaceutical market reached $145.4bn in 2016, dominated by the Cardiovascular therapy area which held 13.6% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 253-page report you will receive 68 tables and 90 figures– all unavailable elsewhere.

The 253-page report provides clear detailed insight into the Chinese Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Chinese Pharmaceutical Market Forecast 2017-2027

Report Scope

Chinese Pharmaceutical market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by therapy area:
– Cardiovascular: including specific revenue forecasts for Hypertension and Dyslipidaemia
– Anticancer
– Infectious Diseases
– Diabetes
– Respiratory:
including specific revenue forecasts for Asthma and COPD
– Central Nervous System:
including specific revenue forecasts for Antidepressants
– Autoimmune
– Others

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading product class:
– Small Molecules: further broken down into Generics Drugs and Branded Drugs
– Traditional Chinese Medicine
– Biologics: further broken down into Biologics (branded), Vaccines and Biosimilars

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading type of drug:
– Generic Prescription Drugs
– Over-the-Counter (OTC) Drugs
– Patented Prescription Drugs

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.

• This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by sales channel:
– Hospitals
– Retail Pharmacies
– Grassroots Clinics

This report lists and discusses the domestic pharmaceutical companies that dominate each submarket.

• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT) that influence the Chinese Pharmaceutical Market. It also analyses social, technological, economic and political factors (STEP) that influence the Chinese Pharmaceutical Market

• Our study ranks and provides 2016 revenues as well as market share of the top 50 domestic Chinese Pharmaceutical companies and top 10 Multinational Pharmaceutical Companies that are the major players in the Chinese Pharmaceutical Market

• Our study lists and discusses the leading domestic and multinational Contract Research Organizations (CRO) that dominate the Chinese Pharmaceutical Market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Chinese Pharmaceutical market. You find data, trends and predictions.

Buy our report today Chinese Pharmaceutical Market Forecast 2017-2027: Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter (OTC) Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots Clinics, Domestic Pharmaceutical Companies, Multinational Pharmaceutical Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Chinese Pharmaceutical Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Chinese Pharmaceutical Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories